JP2008508302A5 - - Google Patents

Download PDF

Info

Publication number
JP2008508302A5
JP2008508302A5 JP2007523807A JP2007523807A JP2008508302A5 JP 2008508302 A5 JP2008508302 A5 JP 2008508302A5 JP 2007523807 A JP2007523807 A JP 2007523807A JP 2007523807 A JP2007523807 A JP 2007523807A JP 2008508302 A5 JP2008508302 A5 JP 2008508302A5
Authority
JP
Japan
Prior art keywords
oil
composition
acid
salt
weight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2007523807A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008508302A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2005/026783 external-priority patent/WO2006015120A2/en
Publication of JP2008508302A publication Critical patent/JP2008508302A/ja
Publication of JP2008508302A5 publication Critical patent/JP2008508302A5/ja
Withdrawn legal-status Critical Current

Links

JP2007523807A 2004-07-28 2005-07-28 αコハク酸トコフェリル、そのアナログおよび塩の安定な注射用組成物 Withdrawn JP2008508302A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US59209704P 2004-07-28 2004-07-28
PCT/US2005/026783 WO2006015120A2 (en) 2004-07-28 2005-07-28 Stable injectable composition of alpha tocopheryl succinate, analogues and salts thereof

Publications (2)

Publication Number Publication Date
JP2008508302A JP2008508302A (ja) 2008-03-21
JP2008508302A5 true JP2008508302A5 (enExample) 2008-09-04

Family

ID=35787824

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007523807A Withdrawn JP2008508302A (ja) 2004-07-28 2005-07-28 αコハク酸トコフェリル、そのアナログおよび塩の安定な注射用組成物

Country Status (11)

Country Link
US (1) US20060024360A1 (enExample)
EP (1) EP1778217A4 (enExample)
JP (1) JP2008508302A (enExample)
KR (1) KR20070059072A (enExample)
CN (1) CN1925853B (enExample)
AU (1) AU2005269383A1 (enExample)
CA (1) CA2575216A1 (enExample)
IL (1) IL180741A0 (enExample)
NO (1) NO20070983L (enExample)
RU (1) RU2007107359A (enExample)
WO (1) WO2006015120A2 (enExample)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7871632B2 (en) * 2004-07-12 2011-01-18 Adventrx Pharmaceuticals, Inc. Compositions for delivering highly water soluble drugs
US8557861B2 (en) * 2004-09-28 2013-10-15 Mast Therapeutics, Inc. Low oil emulsion compositions for delivering taxoids and other insoluble drugs
US20080038316A1 (en) * 2004-10-01 2008-02-14 Wong Vernon G Conveniently implantable sustained release drug compositions
TWI376239B (en) * 2006-02-01 2012-11-11 Andrew Xian Chen Vitamin e succinate stabilized pharmaceutical compositions, methods for the preparation and the use thereof
CN101011355B (zh) * 2006-02-01 2013-01-02 陈献 经维生素e琥珀酸酯稳定的医药组合物、其制备及用途
US20080045589A1 (en) * 2006-05-26 2008-02-21 Susan Kelley Drug Combinations with Substituted Diaryl Ureas for the Treatment of Cancer
CA2663474C (en) 2006-09-15 2017-06-27 Griffith University Pro-oxidant anti-cancer compounds
NZ555163A (en) * 2007-05-14 2010-05-28 Fonterra Co Operative Group Methods of immune or hematological enhancement, inhibiting tumour formation or growth, and treating or preventing cancer, cancer symptoms, or the symptoms of cancer treatments
CN101677987A (zh) * 2007-06-22 2010-03-24 赛多斯有限责任公司 不含吐温80的多西他赛的增溶制剂
KR101642157B1 (ko) 2008-03-14 2016-07-22 스티븐 존 랄프 미토콘드리아로 전달되는 항암 화합물
US20100260830A1 (en) * 2009-04-08 2010-10-14 Brian A Salvatore Liposomal Formulations of Tocopheryl Amides
WO2011004552A1 (ja) * 2009-07-09 2011-01-13 国立大学法人九州大学 水溶性薬物キャリア及びその製造方法
US20110213025A1 (en) * 2009-08-10 2011-09-01 Proviflo, Llc Catheter Lock Solutions Utilizing Tocopherol and Mid-Chain Fatty Acids
WO2011025771A1 (en) * 2009-08-25 2011-03-03 Biogen Idec Ma Inc. Compositions for delivery of insoluble agents
US8912228B2 (en) 2009-10-19 2014-12-16 Scidose Llc Docetaxel formulations with lipoic acid
US8541465B2 (en) * 2009-10-19 2013-09-24 Scidose, Llc Docetaxel formulations with lipoic acid and/or dihydrolipoic acid
US8476310B2 (en) 2009-10-19 2013-07-02 Scidose Llc Docetaxel formulations with lipoic acid
US7772274B1 (en) 2009-10-19 2010-08-10 Scidose, Llc Docetaxel formulations with lipoic acid
US20110092579A1 (en) * 2009-10-19 2011-04-21 Scidose Llc Solubilized formulation of docetaxel
UA110383C2 (en) 2011-06-08 2015-12-25 Akzo Nobel Chemicals Int Bv Deicing composition
CN103582686B (zh) 2011-06-08 2016-03-23 阿克佐诺贝尔化学国际公司 防冻组合物
AR088524A1 (es) 2011-11-09 2014-06-18 Akzo Nobel Chemicals Int Bv Composicion descongelante, proceso de preparacion, conjunto de parte y uso
CN104427977B (zh) 2012-05-10 2018-02-02 佩因拉佛姆有限公司 局部麻醉剂的储库制剂及其制备方法
JP6094388B2 (ja) * 2013-06-07 2017-03-15 ニプロ株式会社 ペメトレキセドを含む注射用組成物
JP6087769B2 (ja) * 2013-08-30 2017-03-01 サントリー食品インターナショナル株式会社 烏龍茶抽出物を含有する容器詰飲料
WO2016201269A2 (en) 2015-06-11 2016-12-15 Proviflo, Llc Graft-port hemodialysis systems, devices and methods
PH12022550592A1 (en) * 2016-01-07 2023-07-17 Tesorx Pharma Llc Formulations for treating bladder cancer
US20200138855A1 (en) * 2017-07-20 2020-05-07 Delta-Fly Pharma, Inc. Novel antineoplastic drug based on specificity of cancer-cell metabolism
US12426594B2 (en) 2020-09-24 2025-09-30 Everest Medical Innovation GmbH Cryoprotective compositions and methods for protection of a surgical site during cryosurgery
US12453805B2 (en) 2020-09-24 2025-10-28 Everest Medical Innovation GmbH Cryoprotective compositions, surgical kits, and methods for protection of a surgical site during cryosurgery
CN120365238A (zh) * 2025-05-29 2025-07-25 无锡知妍生物科技有限公司 单生育酚壬二酸酯及其应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3173838A (en) * 1962-03-28 1965-03-16 Eastman Kodak Co Solid, vitamin e-active product and process for making it
US4783220A (en) * 1986-12-18 1988-11-08 Xerox Corporation Vesicle ink compositions
AU675930B2 (en) * 1992-02-18 1997-02-27 Pharmos Corp. Dry compositions for preparing submicron emulsions
US5961970A (en) * 1993-10-29 1999-10-05 Pharmos Corporation Submicron emulsions as vaccine adjuvants
GB9409778D0 (en) * 1994-05-16 1994-07-06 Dumex Ltd As Compositions
GB9514878D0 (en) * 1995-07-20 1995-09-20 Danbiosyst Uk Vitamin E as a solubilizer for drugs contained in lipid vehicles
US6727280B2 (en) * 1997-01-07 2004-04-27 Sonus Pharmaceuticals, Inc. Method for treating colorectal carcinoma using a taxane/tocopherol formulation
US6458373B1 (en) * 1997-01-07 2002-10-01 Sonus Pharmaceuticals, Inc. Emulsion vehicle for poorly soluble drugs
US7030155B2 (en) * 1998-06-05 2006-04-18 Sonus Pharmaceuticals, Inc. Emulsion vehicle for poorly soluble drugs
US20030236236A1 (en) * 1999-06-30 2003-12-25 Feng-Jing Chen Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
US20030005407A1 (en) * 2000-06-23 2003-01-02 Hines Kenneth J. System and method for coordination-centric design of software systems
US20030099674A1 (en) * 2001-08-11 2003-05-29 Chen Andrew X. Lyophilized injectable formulations containing paclitaxel or other taxoid drugs
US20040175415A1 (en) * 2003-03-05 2004-09-09 Chan Alvin C. Formulations and methods of delivery of intact tocopheryl succinate to humans
US7871632B2 (en) * 2004-07-12 2011-01-18 Adventrx Pharmaceuticals, Inc. Compositions for delivering highly water soluble drugs

Similar Documents

Publication Publication Date Title
RU2007107359A (ru) Стабильная инъецируемая композиция альфа-токоферилсукцината, его аналогов и солей
Li et al. A review on phospholipids and their main applications in drug delivery systems
DE69818704T2 (de) Verfahren zur verbesserung der absorption und des transport von lipidlöslichen verbindungen mittels strukturierter glyceriden
Stuchlík et al. Lipid-based vehicle for oral drug delivery
JP2015500241A5 (enExample)
JP2011519349A5 (enExample)
KR102162901B1 (ko) 위장관을 따라 약물을 표적화 방출하기 위한 pH 감응성 담체, 그로부터의 조성물, 및 이들의 제조 및 사용 방법
ES3064797T3 (en) Process for the production of discrete solid extruded particles
WO2003102116A2 (en) Oil-soluble pigment compositions
KR20140074931A (ko) 신규 코팅 시스템
US20110129504A1 (en) Composition for controlling lipase catalyzed reactions
JP2003055219A (ja) マイクロカプセル並びに錠剤、食品用及び医薬品用配合剤
US7645471B2 (en) Processes for coating an animal feed to obtain coated animal feed products
WO2003088761A2 (de) Physiologisch verträgliche, phospholipid-haltige, stabile und harte matrix
KR20050081092A (ko) 생체적합성 친수성 고분자를 포함하는 콜로이드계 조성물,제형 및 이들의 제조 방법
KR20220158031A (ko) pH 의존성 재구성이 가능한 제약 담체 및 그의 제조 및 사용 방법
JP4599604B2 (ja) 生体活性のリン脂質含有成分を含有するマトリックス
JP6445239B2 (ja) ソフトカプセル充填組成物及び該ソフトカプセル充填組成物が充填されたソフトカプセル
JP2000109882A (ja) 油性粉末、製造方法および用途
KR20160033730A (ko) 응고제 및 이것을 이용하는 타이어 펑크 수리 키트
KR20070018008A (ko) 생체 적합성 친수성 고분자를 포함하는 콜로이드계 조성물,제형 및 이들의 제조 방법
JP6949670B2 (ja) 難溶性物質を含有する経口摂取用組成物、難溶性物質の消化管吸収性の向上方法及び難溶性物質を含有する水中油型乳化物の胃内での乳化安定化方法
JP2017214335A (ja) コエンザイムq10組成物及びそれが充填されたソフトカプセル
US20100016269A1 (en) Composition of plant sterol and phosphatidylcholine and method for producing the same
DE10250727B4 (de) Matrix mit einer bioaktiven Phospholipid-haltigen Komponente